Case report of acquired hemophagocytic lymphohistiocytosis associated with progression of monoclonal gammopathy of unknown significance (MGUS)

Abstract

Background: Acquired hemophagocytic lymphohistiocytosis (HLH) is an aggressive hyperinflammatory syndrome. Without prompt diagnosis and proper treatment, it can be life-threatening. HLH is commonly present in the setting of other autoimmune disorders, infection, organ transplantation, and malignancy. However, to our knowledge, HLH associated with monoclonal gammopathy of undetermined significance (MGUS) has not been reported.

Case presentation: A 67-year-old woman with an extensive history of MGUS and renal transplant presented with progressive fatigue, weight loss, intermittent fevers, splenomegaly, and pancytopenia. Serum protein electrophoresis with immunofixation identified a new monoclonal protein IgG lambda and a rapidly increasing pre-existing free kappa light chain. A bone marrow biopsy revealed focal clusters of kappa restricted plasma cells which comprised less than 10\% of marrow cellularity. Skeletal survey was negative for osteolytic lesions. She was also free of any end-organ damage. Histological examination showed a prominent increase in histiocytes and macrophages, many of which show erythrophagocytosis and lymphophagocytosis. Together with her clinical presentation along with a hyperferritinemia, a diagnosis of HLH was confirmed utilizing the criteria of the Histiocyte Society. The patient underwent a splenectomy. Prompt treatment with etoposide and high dose dexamethasone eventually stabilized the patient and resulted in a full recovery, which coincided with the disappearance of the serum monoclonal IgG lambda.

Conclusions: This report reveals a novel association of HLH with the progression of MGUS. Familiarity with this syndrome and its association with other conditions is indicated to ensure prompt diagnosis and appropriate patient treatment.

Keywords

Hemophagocytic lymphohistiocytosis (HLH) / Monoclonal gammopathy of undetermined significance (MGUS) / Transplant

ACKNOWLEDGEMENTS

We would like to acknowledge the University of Pittsburgh School of Medicine Dean’s Faculty Advancement Award funding for Octavia Peck Palmer.

CONFLICTS OF INTEREST DISCLOSURE

No conflicts of interest.

References

[1] Henter JI, Aricò M, Elinder G, et al. Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998; 12: 417-433. PMid:9561910.

[2] Janka G zur Stadt U. Familial and acquired hemophagocytic lymphohistiocytosis. Hematology Am Soc Hematol Educ Program. 2005: 82-88.

[3] Aricò M1, Boggio E, Cetica V, et al. Variations of the UNC13D gene in patients with autoimmune lymphoproliferative syndrome. PLoS One. 2013; 8: e68045. PMid:23840885. https://doi.org/10.1371/journal.pone.0068045

[4] Boggio E, Aricò M, Melensi M, et al. Mutation of FAS, XIAP, and UNC13D genes in a patient with a complex lymphoproliferative phenotype. Pediatrics. 2013; 132: e1052-1058. PMid:24043286. https://doi.org/10.1542/peds.2012-1838

[5] Janka G, Imashuku S, Elinder G, et al. Infection- and malignancy associated hemophagocytic syndromes. Secondary hemophagocytic lymphohistiocytosis. Hematol Oncol Clin North Am. 1998; 12: 435-444. PMid:9561911. https://doi.org/10.1016/S0889-8588(05)70521-9

[6] Hasselblom S, Linde A, Ridell B. Hodgkin’s lymphoma, Epstein-Barr virus reactivation, and fatal haemophagocytic syndrome. J Intern Med. 2004; 255: 289-295. PMid:14746567. https://doi.org/10.1046/j.0954-6820.2003.01249.x

[7] Machaczka M, Vaktnas J. Haemophagocytic syndrome associated with Hodgkin lymphoma and Pneumocystis jiroveci pneumonitis. Br J Haematol. 2007; 138: 672. PMid:17655724. https://doi.org/10.1111/j.1365-2141.2007.06734.x

[8] Janka G. Hemophagocytic lymphohistiocytosis: When the immune system runs amok. Klin Padiatr. 2009; 221: 278-285. PMid:19707989. https://doi.org/10.1055/s-0029-1237386

[9] Henter JI, Horne A, Aricó M, et al. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007; 48: 124-131. PMid:16937360. https://doi.org/10.1002/pbc.21039

[10] Ishii E, Ohga S, Imashuku S, et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol. 2007; 86: 58-65. PMid:17675268. https://doi.org/10.1532/IJH97.07012

[11] Anani W, Fox C, Peck Palmer OM. A 72-year old female with markedly elevated ferritin. Clin Chem. 2015; 61: 561-569. PMid:25725050. https://doi.org/10.1373/clinchem.2014.231993

[12] Allen CE, Yu X, Kozinetz CA, et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2008; 50: 1227-1235. PMid:18085676. https://doi.org/doi:10.1002/pbc.21423

[13] Henter JI, Samuelsson-Horne A, Aricò M, et al. Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood. 2002; 100: 2367-2373. PMid:12239144. https://doi.org/10.1182/blood-2002-01-0172

[14] Diaz-Guzman E, Dong B, Hobbs SB, et al. Hemophagocytic lymphohistiocytosis after lung transplant:report of 2 cases and a literature review. Exp Clin Transplant. 2011; 9: 217-22. PMid:21649574.

[15] Venizelos ID, Garipidou V, Perifanis V. Hemophagocytic syndrome associated with multiple myeloma. Leuk Lymphoma. 2002; 43: 897-899. PMid:12153183. https://doi.org/10.1080/10428190290017079

[16] Créput C, Galicier L, Buyse S, et al. Understanding organ dysfunction in hemophagocytic lymphohistiocytosis. Intensive Care Med. 2008; 34: 1177-1187. PMid:18427781. https://doi.org/10.1007/s00134-008-1111-y